Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Jung

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
BMC Cancer|February 2, 2023
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancerMax Jung, Michael Rose, Ruth Knuechel, et al.
European Urology Focus|April 25, 2021
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?Chiara Maria Lavinia Loeffler, Nadina Ortiz Bruechle, Max Jung, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
BMC Cancer|February 2, 2023
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancerMax Jung, Michael Rose, Ruth Knuechel, et al.
European Urology Focus|April 25, 2021
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?Chiara Maria Lavinia Loeffler, Nadina Ortiz Bruechle, Max Jung, et al.
Pageof 1